Hydrochlorothiazide (HCTZ) group showed the best prognosis (79.1%) among different antihypertensive drug, particularly for advance stage or elderly patients, which are poor prognostic factors for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback